Literature DB >> 21215536

Impact of pre-ovulatory follicle diameter on plasma estradiol, subsequent luteal profiles and conception rate in buffalo (Bubalus bubalis).

A K Pandey1, G S Dhaliwal, S P S Ghuman, S K Agarwal.   

Abstract

The present study was designed to investigate the impact of pre-ovulatory follicle (POF) diameter on the day of estrus on plasma estradiol concentration, subsequent luteal profile (corpus luteum, CL, diameter and plasma progesterone concentration) and conception rate in buffaloes. Twenty-eight buffaloes were synchronized with synthetic analogue of prostaglandin F(2α) (PGF(2α)) administered 11 days apart. Transrectal ultrasonography and jugular vein blood sampling was carried out on the day of estrus and on days 0 (day of ovulation), 5, 12, 16 and 21 post-ovulation. Out of 28 buffaloes, 11 (39.3%) were diagnosed pregnant on day 40 post-ovulation. Retrospective analysis revealed that the buffaloes getting pregnant had larger (p<0.05) POF diameter. In fact, all the buffaloes (n=5/5) having POF diameter between >14 and 16 mm conceived, whereas, conception rate in buffaloes with POF diameter between >12 and ≤14 mm (n=6/17) or <12 mm (n=0/6) was 35.3% and 0.0%, respectively. A positive correlation (r=0.57, p<0.05) was observed between POF diameter and plasma estradiol concentration at estrus. On day 5 post-ovulation, luteal profile was positively correlated (CL: r=0.34, p<0.05; plasma progesterone concentration: r=0.27, p>0.05) with POF diameter. Further, on the same day, plasma progesterone concentration was positively correlated (r=0.47, p<0.05) with CL diameter, however, this correlation was absent (r=0.05, p>0.05) during the subsequent luteal phase. Nevertheless, the post-ovulation luteal profile of pregnant buffaloes was higher (p<0.05) compared to non-pregnant counterparts. In conclusion, the diameter of POF in buffaloes has positive impact on plasma estradiol concentration at estrus, post-ovulation luteal profile and conception rate. The diameter of CL can be used as an indicator of luteal function at early but not at mid or late luteal phase of estrus cycle in buffaloes.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21215536     DOI: 10.1016/j.anireprosci.2010.12.003

Source DB:  PubMed          Journal:  Anim Reprod Sci        ISSN: 0378-4320            Impact factor:   2.145


  5 in total

1.  Impact of norgestomet supplementation during early luteal phase on subsequent luteal profiles and conception rate in buffalo: a preliminary study.

Authors:  Anand Kumar Pandey; Gurcharan Singh Dhaliwal; Sarvpreet Singh Ghuman; Jagir Singh; Ajeet Kumar; Sudhir Kumar Agarwal
Journal:  Trop Anim Health Prod       Date:  2012-07-18       Impact factor: 1.559

2.  Pregnancy rate in water buffalo following fixed-time artificial insemination using new or used intravaginal devices with two progesterone concentrations.

Authors:  J C Gutiérrez-Añez; R A Palomares; J R Jiménez-Pineda; A R Camacho; G E Portillo-Martínez
Journal:  Trop Anim Health Prod       Date:  2017-12-22       Impact factor: 1.559

3.  Comparative efficacy of E-17β and GnRH administration on day 0 of a controlled internal drug release (CIDR) based protocol on synchrony of wave emergence, ovulation and conception rates in Murrah buffalos (Bubalus bubalis).

Authors:  G R Bhat; G S Dhaliwal; S Ghuman; M Honparkhe
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

4.  Comparison of ovsynch and progesterone-based protocol for induction of synchronized ovulation and conception rate in subestrous buffalo during low-breeding season.

Authors:  S Ghuman; M Honparkhe; J Singh
Journal:  Iran J Vet Res       Date:  2014       Impact factor: 1.376

5.  Endometritis impairs luteal development, function, and nitric oxide and ascorbic acid concentrations in buffalo (Bubalus bubalis).

Authors:  Megha Pande; Goutam Kumar Das; Firdous Ahmad Khan; Mihir Sarkar; Mohan Chandra Pathak; Jai Kishan Prasad; Harendra Kumar
Journal:  Trop Anim Health Prod       Date:  2012-10-16       Impact factor: 1.559

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.